Form 4: Molina Healthcare Director Receives Equity Award

Steven J. Orlando, a Director at Molina Healthcare, Inc., was granted 237 shares of common stock valued at $55,000 as part of his annual equity award.

Summary

• Steven J. Orlando, a Director of Molina Healthcare, Inc. (MOH), received a grant of 237 shares of common stock on July 1, 2026.
• This grant is part of the company's 2025 Equity Incentive Plan and is in connection with his services as a Director.
• The annual equity award for directors is set at $220,000, with one quarter ($55,000) granted on the first day of each quarter.
• The number of shares granted is based on the closing price of the Issuer's common stock on the grant date, which was $232.55 on July 1, 2026.
• Following this transaction, Orlando beneficially owns 17,967 shares held indirectly through a trust, and 1,500 shares held in his 401(k) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine equity grant to a director as part of established compensation, rather than a significant event impacting the company's financial performance or strategic direction.

Positives

• Director compensation aligns with company performance through equity grants tied to stock price.
• Regular quarterly equity grants demonstrate a consistent incentive structure for directors.
• The grant value of $55,000 for the quarter is a clear and defined component of the director compensation package.

Risks

• The value of future equity grants is subject to the volatility of Molina Healthcare's stock price.
• Potential for conflicts of interest if director compensation is not structured to align with long-term shareholder value.

Future Outlook

The filing indicates a recurring quarterly equity grant structure for directors, suggesting a continued commitment to incentivizing leadership through stock ownership.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the healthcare and managed care industry, serving to align executive and director interests with those of shareholders. The structure of these grants, tied to stock performance and awarded quarterly, is typical for publicly traded companies seeking to retain and motivate key leadership.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grant aligns director compensation with stock performance, potentially encouraging decisions that benefit shareholders.
• Employees: The filing does not directly impact employees, but the incentive structure for directors may indirectly influence company strategy.
• Management: Reinforces the established compensation structure for directors.

Next Steps

• Continued quarterly equity grants to directors as per the 2025 Equity Incentive Plan.
• Steven J. Orlando will continue to hold shares through his trust and 401(k) plan.

Key Dates

Keywords

Molina Healthcare, MOH, Form 4, Director, Equity Award, Stock Grant, Beneficial Ownership, Steven J. Orlando, SEC Filing, Insider Trading